Clinical evaluation of deep learning‐enhanced lymphoma pet imaging with accelerated acquisition
Journal of Applied Clinical Medical Physics · 2024
DOI: 10.1002/acm2.14390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Clinical Medical Physics, 2024. Verfasst von Xu Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Science…. Hauptthemen laut MEDLINE: Deep Learning, Lymphoma, Fluorodeoxyglucose F18, Signal-To-Noise Ratio. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
This study aims to evaluate the clinical performance of a deep learning (DL)‐enhanced two‐fold accelerated PET imaging method in patients with lymphoma.
Methods
A total of 123 cases devoid of lymphoma underwent whole‐body 18F‐FDG‐PET/CT scans to facilitate the development of an advanced SAU2Net model, which combines the advantages of U2Net and attention mechanism. This model integrated inputs from simulated 1/2‐dose (0.07 mCi/kg) PET acquisition across multiple slices to generate an estimated standard dose (0.14 mCi/kg) PET scan. Additional 39 cases with confirmed lymphoma pathology were utilized to evaluate the model's clinical performance. Assessment criteria encompassed peak‐signal‐to‐noise ratio (PSNR), structural similarity index (SSIM), a 5‐point Likert scale rated by two experienced physicians, SUV features, image noise in the liver, and contrast‐to‐noise ratio (CNR). Diagnostic outcomes, including lesion numbers and Deauville score, were also compared.
Results
Images enhanced by the proposed DL method exhibited superior image quality ( P < 0.001) in comparison to low‐dose acquisition. Moreover, they illustrated equivalent image quality in terms of subjective image analysis and lesion maximum standardized uptake value (SUVmax) as compared to the standard acquisition method. A linear regression model with y = 1.017x + 0.110 () can be established between the enhanced scans and the standard acquisition for lesion SUVmax. With enhancement, increased signal‐to‐noise ratio (SNR), CNR, and reduced image noise were observed, surpassing those of the standard acquisition. DL‐enhanced PET images got diagnostic results essentially equavalent to standard PET images according to two experienced readers.
Conclusion
The proposed DL method could facilitate a 50% reduction in PET imaging duration for lymphoma patients, while concurrently preserving image quality and diagnostic accuracy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
- RadioDynamic Healthcare, Shanghai, People's Republic of China.
- Laboratory for Intelligent Medical Imaging, Tsinghua Cross-strait Research Institute, Beijing, People's Republic of China.
- Department of Engineering Physics, Tsinghua University, Beijing, People's Republic of China.
ORCID-Profile: Boyang Pan
Zitieren
APA
Li, X., Pan, B., Chen, C., Yan, D., Pan, Z., Feng, T., Liu, H., Gong, N. J., & Liu, F. (2024). Clinical evaluation of deep learning‐enhanced lymphoma pet imaging with accelerated acquisition. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.14390
Vancouver
Li X, Pan B, Chen C, Yan D, Pan Z, Feng T, et al. Clinical evaluation of deep learning‐enhanced lymphoma pet imaging with accelerated acquisition. Journal of Applied Clinical Medical Physics. 2024. doi:10.1002/acm2.14390
BibTeX
@article{Li2024,
author = {Li, Xu and Pan, Boyang and Chen, Congxia and Yan, Dongyue and Pan, Zhenglin and Feng, Tao and Liu, Hui and Gong, Nan-Jie and Liu, Fugeng},
title = {Clinical evaluation of deep learning‐enhanced lymphoma pet imaging with accelerated acquisition},
journal = {Journal of Applied Clinical Medical Physics},
year = {2024},
doi = {10.1002/acm2.14390}
}
EUVIMED